NCT03683147: Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast Cancer

NCT03683147
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must have an MBC diagnosis within the past 5 years & treated at Roswell Park Cancer Institute
Exclusions: 
https://ClinicalTrials.gov/show/NCT03683147

Comments are closed.

Up ↑